Abstract
Transcatheter aortic valve replacement (TAVI), though a preferred treatment option in the elderly population carrying increased risks for open heart surgery, may result in prognosis-limiting moderate or severe aortic regurgitation. Here, we report a series of 11 patients from 3 German TAVI centers, suffering from moderate- to high-grade aortic regurgitation after CoreValve implantation, who were subsequently treated by Edwards Sapien XT implantation.
Methods
The patients were 79.5 ± 4.2 years of age and presented between November 2009 and February 2013 with a symptomatic high-grade aortic stenosis (mean maximum gradient 57 ± 22 mmHg) and EuroSCORE of 16 ± 7 %. Initial implantation of a Medtronic CoreValve resulted in moderate-to-severe aortic regurgitation (grade 2.64 ± 0.37) although postdilatation was attempted in eight cases and snare repositioning was attempted in one case.
Results
All 11 patients were treated by a Sapien XT (Edwards) valve implanted into the initially deployed CoreValve: four via transfemoral, one via transaortical and six via transapical approaches. Successful implantation was possible in all 11 patients resulting in a reduction of aortic regurgitation to mean grade 0.23 ± 0.39. Two patients required permanent pacemaker. After 30 days, ten patients were alive, whereas one patient succumbed to pneumonia complicating advanced chronic obstructive pulmonary disease.
Conclusion
In the instance of moderate or severe aortic regurgitation after TAVI of a CoreValve, transfemoral or transapical Sapien XT valve-in-valve deployment is an excellent option to reduce residual regurgitation to none or mild.
Similar content being viewed by others
References
Smith CR et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198
Makkar RR et al (2012) Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 366(18):1696–1704
Kodali SK et al (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366(18):1686–1695
Ussia GP et al (2012) Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur Heart J 33(8):969–976
Tamburino C et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3):299–308
Zahn R et al (2011) Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValveTM prosthesis due to a too-low implantation, using transcatheter repositioning. J Heart Valve Dis 20(1):64–69
Leon MB et al (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the valve academic research consortium. J Am Coll Cardiol 57(3):253–269
Vasa-Nicotera M et al (2012) Impact of paravalvular leakage on outcome in patients after transcatheter aortic valve implantation. JACC Cardiovasc Interv 5(8):858–865
Gripari P et al (2012) Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart 98(16):1229–1236
Buzzatti N et al (2012) Computed tomography-based evaluation of aortic annulus, prosthesis size and impact on early residual aortic regurgitation after transcatheter aortic valve implantation. Eur J Cardiothorac Surg 43:43–50
Willson AB et al (2012) 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. J Am Coll Cardiol 59(14):1287–1294
Takagi K et al (2011) Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 78(3):432–443
Patsalis PC et al (2012) Incidence, outcome and correlates of residual paravalvular aortic regurgitation after transcatheter aortic valve implantation and importance of haemodynamic assessment. EuroIntervention 8:1398–1406
Moat NE et al (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom transcatheter aortic valve implantation) Registry. J Am Coll Cardiol 58(20):2130–2138
Abdel-Wahab M et al (2011) Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97(11):899–906
Unbehaun A et al (2012) Transapical aortic valve implantation: incidence and predictors of paravalvular leakage and transvalvular regurgitation in a series of 358 patients. J Am Coll Cardiol 59(3):211–221
Seiffert M et al (2012) Predictors and outcomes after transcatheter aortic valve implantation using different approaches according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 82:640–652
Detaint D et al (2009) Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2(9):821–827
Zahn R et al (2011) Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32(2):198–204
Hutter A et al (2010) Aortic annulus evaluation in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 76(7):1009–1019
Napodano M et al (2011) Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. Catheter Cardiovasc Interv 78(7):996–1003
Eggebrecht H et al (2012) Interventional options for severe aortic regurgitation after transcatheter aortic valve implantation: balloons, snares, valve-in-valve. Clin Res Cardiol 101(6):503–507
Leber AW et al (2011) Aortic valve calcium score as a predictor for outcome after TAVI using the CoreValve revalving system. Int J Cardiol 166:652–657
Greif M et al (2012) Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clin Res Cardiol 101(12):993–1001
Conflict of interest
All authors declare that they have no potential conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
P. Diemert, P. Lange, and M. Greif contributed equally to this work.
G. Schymik and C. Kupatt share last authorship.
Rights and permissions
About this article
Cite this article
Diemert, P., Lange, P., Greif, M. et al. Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol 103, 183–190 (2014). https://doi.org/10.1007/s00392-013-0632-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0632-8